Share this post on:

Product Name :
Tulobuterol

Search keywords :
Tulobuterol

drugId :
null

Target Vo:
Beta-2 adrenergic receptor

Target Vo Short Name :
ADRB2

Moa_Name:
Beta-2 adrenergic receptor agonists

First Approval Country :
Japan

First Approval Date Filter:
1998

Origin Company_Name :

Active Company_Name :
Abbott Laboratories

Active Indication_Name:
Respiratory Distress Syndrome, Adult

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-RSK1 p90 (Thr359/Ser363) Antibody
Met (C-Met) Antibody
Cortactin Antibody: Cortactin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Cortactin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related